Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
What’s Behind the Strong Growth of the Viscosupplementation Market Size in the Last 5 Years?
The market size for viscosupplementation has experienced robust expansion in the previous years. It is set to swell from a valuation of $4.1 billion in 2024 to $4.5 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.8%. Factors such as an aging demographic, increasing rates of obesity, expanded insurance coverage, heightened awareness, patient preferences, and a rise in osteoarthritis cases have contributed to the growth in the historic period.
In the coming years, the viscosupplementation market is forecasted to witness substantial growth, reaching $6.67 billion in 2029 with a compound annual growth rate (CAGR) of 10.3%. The boom during this forecast period is likely due to factors such as regulatory backing, alternative payment systems, a surge in healthcare spending, research and development efforts, and the broadening of indications. Amongst notable trends projected for the forecast period are outcome-driven payment schemes, initiatives to educate patients, the growth in biomarker development, research into gene therapy, and value-based care models.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Drivers Are Powering the Rise of the Viscosupplementation Market?
The viscosupplementation market’s expansion is expected to be driven by the increasing prevalence of osteoarthritis. This problematic joint disease, often referred to as the most usual form of arthritis, results in the breakdown of the joints, with the hips, knees, and hands most commonly affected. Viscosupplementation treatments, using hyaluronic acid injections into the bone joints, can relieve pain and enhance smooth bone movement, thereby reducing discomfort and boosting bone function. For example, projections from the US’s Centers for Disease Control and Prevention (CDC) indicate that by 2040, 78.4 million adults aged 18 years and older in the USA will have arthritis.
As a result, the escalating prevalence of osteoarthritis is propelling the viscosupplementation market’s growth.
How Is the Viscosupplementation Market Structured Across Key Segments?
The viscosupplementation market covered in this report is segmented –
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
How Will Market Trends Drive Strategic Shifts in the Viscosupplementation Sector?
Pioneering corporations in the viscosupplementation market are directing their efforts towards the creation of novel products like resorbable, hyaluronic acid scaffolds. These innovative products are designed to boost joint lubrication, stimulate tissue regeneration and offer durable relief from symptoms of osteoarthritis, in turn enhancing patient results and widening available treatment possibilities. Constructed mainly from hyaluronic acid (HA), a polysaccharide located naturally in connective tissues, a resorbable hyaluronic acid scaffold is both biocompatible and biodegradable. An example is Hyalofast, a cutting-edge, resorbable, hyaluronic acid scaffold for cartilage repair, launched in May 2023 by Anika Therapeutics, Inc, a US-based orthopedics provider. Hyalofast’s design incorporates a hyaluronic acid-based solution aimed at preserving joints, potentially providing a substitute to more invasive surgical procedures.
Where Is the Viscosupplementation Market Experiencing the Fastest Regional Growth?
North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Leading Players Shaping the Future of the Viscosupplementation Industry
Major companies operating in the viscosupplementation market include Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd., SingHealth Group
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…px?id=9836
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
